Arsenal Capital Partners acquires ThermoSafe to strengthen cold chain technology and healthcare logistics capabilities
Key takeaways
- Arsenal Capital Partners acquired ThermoSafe to expand its role in temperature-controlled logistics for healthcare supply chains.
- ThermoSafe’s packaging technologies support the safe transport of pharmaceuticals, biologics, and vaccines worldwide.
- The acquisition positions ThermoSafe for accelerated growth and innovation in global cold chain efficiency.
Arsenal Capital Partners recently completed its acquisition of ThermoSafe from Sonoco Products Company.
The company, which specializes in building industrial growth and healthcare businesses, acquired ThermoSafe, a global provider of temperature assurance technologies based in Arlington Heights, Illinois. ThermoSafe’s solutions ensure the safe and efficient transport of pharmaceuticals, biologics, vaccines, and other healthcare products through advanced insulation materials and reusable packaging systems.
ThermoSafe operates a vertically integrated network that delivers refrigerated, frozen, and controlled-room-temperature applications. Its ISC Labs offers customized design, testing, and validation services to meet stringent regulatory standards.
“ThermoSafe’s leadership in cold chain solutions aligns with Arsenal’s focus on partnering with and helping to build businesses that deliver innovation and lasting value,” George Abd, an operating partner of Arsenal, stated. “With decades of domain and technical expertise in the technology-rich industrial growth sectors, Arsenal is looking forward to partnering with Jim Lassiter and his team to further strengthen ThermoSafe’s position as a value-added partner providing innovative solutions to its markets and customers.”
This piece was created with the assistance of generative AI tools and was edited by our content team for clarity and accuracy.